bio vs NAFIC

bio:cap – the new international Investival for innovators and investors in life sciences and artificial intelligence Meet the world halfway between North America and Asia – in Berlin! From June 9–11, 2026, Germany’s capital will become a central hub for life sciences in Europe and across the globe. From biotech and TechBio to diagnostics and artificial intelligence – this is where bold scientific and industrial innovation meets capital and politics. bio:cap is hosted by Messe Berlin in cooperation with leading institutions in science and medicine. Held under the patronage of Charité – Universitätsmedizin Berlin and the Berlin Institute of Health (BIH), and supported by the Hasso Plattner Institute (HPI), the event breaks traditional boundaries and creates a new platform for interdisciplinary exchange. The goal: to connect investors, start-ups, and top life science innovators with the global pharma industry, leading AI pioneers, and political stakeholders. Together, they will discover groundbreaking ideas, invest in high-potential ventures, and help shape the societal and political framework for the life science and innovation landscape of tomorrow. Because while Europe excels in cutting-edge research, it still has untapped potential when it comes to translating discoveries into market success and scalable growth.

NAFIC is a private network for members and their invited guests. Members and approved guests can: • Access exclusive gatherings and partner-hosted events in-person and online • Connect with mutually interested members worldwide • Learn from peers and domain experts across a range of fields • Earn community tokens for engagement and participation Access is by invitation only. New users require membership approval and account setup prior to accessing the platform. Nothing on this platform constitutes financial advice, investment recommendations, or solicitation of any kind.